Substituted phenylpiperidines and phenylpyridines as reversible selective inhibitors of monoamine oxidase type A in rodent brain and liver.
Kula
N S
NS
Department of Psychiatry, Harvard Medical School, Belmont, MA.
Baldessarini
R J
RJ
Murphy
F
F
Neumeyer
J L
JL
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D015655:1-Methyl-4-phenylpyridinium; D000818:Animals; D001921:Brain / Q000201:enzymology*; D008099:Liver / Q000201:enzymology*; D008297:Male; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D011725:Pyridines / Q000494:pharmacology*; D011726:Pyridinium Compounds / Q000494:pharmacology*; D051381:Rats; D013329:Structure-Activity Relationship
D008996:Monoamine Oxidase Inhibitors; D011725:Pyridines; D011726:Pyridinium Compounds; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D015655:1-Methyl-4-phenylpyridinium